secwatch.observer — SEC 8-K summary
======================================

Issuer:     Passage BIO, Inc. (PASG)
CIK:        0001787297
Form:       8-K
Filed at:   2025-05-30T23:59:59+00:00
Accession:  0001104659-25-054907
Event type: other_material
Sentiment:  neutral
Materiality: 0.45
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Passage Bio stockholders elect two directors, ratify KPMG, authorize reverse stock split
--------------------------------------------------------------------------------

- Maxine Gowen, Ph.D. and Dolan Sondhi, Ph.D. elected as Class II directors for three-year terms.
- Ratification of KPMG LLP as independent auditor for FY 2025 with 49.46M shares for, 70.7K against.
- Approval granted for Board to implement reverse stock split at ratio 1:5 to 1:50, by Dec 31, 2025.
- No broker non-votes on proposals 2 and 3; 13.59M broker non-votes on director election.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1787297/000110465925054907/0001104659-25-054907-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1787297/000110465925054907/tm2516589d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-25-054907

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer